Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011
Operating activities:
Net income (loss)	$ (167,575)	$ 3,325	$ 18,757
Reconciliation of net income (loss) to cash provided by operating activities:
Depreciation, depletion, amortization, and accretion	116,912	80,985	75,747
Impairments of long-lived assets	34,842	9,578	8,360
Impairment of goodwill	64,295	0
Provision (benefit) for deferred income taxes	(350)	(9,824)	(2,012)
Equity-based compensation expense	6,775	6,724	9,441
Provision for doubtful accounts	856	374	(237)
Excess decommissioning/abandoning costs	72,724	75,312	40,767
Other non-cash charges and credits	(814)	(10,165)	(6,527)
Acquisition and transaction financing fees	9,869	0
(Gain) loss on sale of property, plant, and equipment	(11)	(5,776)	(4,916)
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	(7,866)	14,139	(31,229)
Inventories	(21,528)	3,011	(3,749)
Prepaid expenses and other current assets	(197)	12,281	(1,335)
Trade accounts payable and accrued expenses	67,508	(16,192)	7,291
Decommissioning liabilities	(63,319)	(114,109)	(94,419)
Other	(3,476)	(7)	1,730
Net cash provided by operating activities	108,645	49,656	17,669
Investing activities:
Purchases of property, plant, and equipment	(131,609)	(101,379)	(107,524)
Acquisition of businesses, net of cash acquired	(854,031)	0	(163,305)
Proceeds from sale of property, plant, and equipment	17,527	1,794	59,325
Other investing activities	374	(440)	4,817
Net cash provided by (used in) investing activities	(967,739)	(100,025)	(206,687)
Financing activities:
Proceeds from long-term debt	837,519	140,971	88,426
Principal payments on long-term debt	(289,900)	(120,664)	(28,597)
Excess tax benefit from equity-based compensation	0	0	198
Proceeds from issuance of Compressco Partners' common units, net of underwriters' discount	363,149	0	0
CSI Compressco's distributions	(12,569)	(4,846)	(4,513)
Proceeds from sale of common stock and exercise of stock options	1,032	2,251	784
Deferred financing costs	(27,587)	(1,978)	0
Net cash provided by (used in) financing activities	871,644	15,734	56,298
Effect of exchange rate changes on cash	(2,920)	(659)	2,356
Increase (decrease) in cash and cash equivalents	9,630	(35,294)	(130,364)
Cash and cash equivalents at beginning of period	38,754	74,048	204,412
Cash and cash equivalents at end of period	48,384	38,754
Supplemental cash flow information:
Interest paid	33,092	17,728	18,711
Taxes paid (refunded)	$ 8,729	$ 7,438	$ 8,020